Comparison of matched samples was done by Wilcoxon test
Conclusion Once established, managing obesity in individuals with PWS is challenging due to the complex interplay of contributors to hyperphagia and obesity, including metabolic, hormonal, behavioral, and neurological factors
The scenario could create a pathway for the GIC to eventually resume covering GLP-1 drugs, commissioners said
Biological & Pharmaceutical Bulletin
Patients with certain genetic profiles may reach their optimal response at lower doses, saving time and reducing unnecessary side effects, while others benefit from advancing more aggressively to reach higher therapeutic levels
View Our Interactive Dashboard on GLP-1RA Therapies in Development (Free Excel Available) Our view With the rise in urbanization, affluence and sedentary lifestyles, the incidence of diabetes, heart and liver diseases and obesity is increasing